Lidocaine and Pain Management in First Trimester Abortions

Completed · Not applicable

Conditions studied: Pain

In brief

The purpose of this study is to examine the effect of lidocaine (a numbing medication) inside the uterus on patient pain during an early abortion, compared to the paracervical block (lidocaine injected on either side of the cervix).

Key facts

Study ID

NCT00613821

Run by

Oregon Health and Science University

People needed

80

Starts

2007-09-01

Expected to finish

2008-05-01

Last updated by the study team

2017-07-31

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Good general health
• Age>18years
• English speaking
• Voluntarily requesting pregnancy termination
• Have an estimated gestation of up to 76 days since the first day of the preceding menstrual period
• Confirmed by ultrasound
• Be able and willing to sign an informed consent
• Agree to the terms of the study
• All patients must be premedicated with Ibuprofen and Valium (per clinic protocols)

You may not qualify if…

• Significant physical or mental health condition
• A gestational age of 77 days or more
• Adnexal mass or tenderness on pelvic exam consistent with pelvic inflammatory disease
• Patients who require or request IV/intramuscular sedation
• Patients who refuse Ibuprofen, Valium and/or paracervical blocks
• Patients allergic to lidocaine
• Patients with known hepatic disease
• Patients weighing less than 100 lbs

Where it is running

• Planned Parenthood of the Columbia Willamette — Portland, Oregon, United States
• Oregon Health and Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.